Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
GTII.CN
STRONG BUYGreen Thumb Industries Inc. · Healthcare · United States · $1.7B · Avg Vol: $1M/d
COMPANY DESCRIPTION
Green Thumb Industries Inc. is a leading national cannabis consumer packaged goods company and retailer in the United States. The company's competitive moat is its extensive footprint of operational retail locations (RISE dispensaries) and state-of-the-art cultivation facilities across highly restricted, limited-license state markets. Green Thumb operates as a highly profitable, vertically integrated market leader, consistently delivering strong cash flows and industry-leading margins.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.0B | 1.1B | 1.1B | 1.2B | 4.9% | 1.2B | 1.2B | 1.3B | 4.2% |
| EPS | 0.05 | 0.15 | 0.31 | 0.49 | 114.0% | 0.51 | — | — | — |
| Shares | 236.0M | 235.4M | 235.6M | 230.5M | -2.3% | 195.1M | — | — | — |
| Debt | 535.9M | 570.3M | 530.7M | 518.3M | -1.1% | 562.4M | — | — | — |
| Equity | 1.7B | 1.7B | 1.8B | 1.9B | 4.6% | — | — | — | — |
| Op CF | 158.6M | 225.0M | 195.2M | 294.9M | 23.0% | 296.5M | — | — | — |
| Inv CF | -219.9M | -227.9M | -89.5M | -130.4M | — | — | — | — | — |
| Fin CF | 8.6M | -13.1M | -95.6M | -50.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GTII.CN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| GTII.CN | Green Thumb Industries Inc.(you) | $1.7B | 94 | STRONG BUY |
| ANIP | ANI Pharmaceuticals, Inc. | $1.9B | 97 | STRONG BUY |
| COLL | Collegium Pharmaceutical, Inc. | $1.2B | 96 | STRONG BUY |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.5B | 96 | STRONG BUY |
| PCRX | Pacira BioSciences, Inc. | $993M | 91 | STRONG BUY |
| IRWD | Ironwood Pharmaceuticals, Inc. | $680M | 98 | STRONG BUY |
| PBH | Prestige Consumer Healthcare Inc. | $2.3B | 78 | BUY |
| INDV | Indivior Pharmaceuticals, Inc. | $4.9B | 90 | STRONG BUY |
| PAHC | Phibro Animal Health Corporation | $1.3B | 73 | BUY |
| LNTH | Lantheus Holdings, Inc. | $7.1B | 93 | STRONG BUY |
Peer medians: ROE -21.3% · P/E 27.3x · Gross margin 44.3%